Adding a T-cell receptor to CAR T cells may reduce side effects of immunotherapies designed to target solid tumors.
All tagged immunology
Adding a T-cell receptor to CAR T cells may reduce side effects of immunotherapies designed to target solid tumors.
U of U Health scientists open the door to clinical advances by examining the ways disease impacts the body, molecule by molecule.
Immune cells convert an immunosuppressive lipid into an anticancer immunity enhancer.
An immune signal that reprograms fat metabolism could help control nonalcoholic fatty liver disease.
Artificial intelligence untangles the cellular signals that matter for anticancer immunity.
A potential new marker for immunotherapy response could help guide treatment decisions.
Elusive tumor-targeting T cells share a telltale gene activity signature.
Scientists’ CRISPR toolkit expands as researchers explore the natural diversity of bacterial immune systems.
Restabilizing a natural barricade could reduce inflammation and protect neurons in patients with multiple sclerosis.